Evaluation of cardiac structure by echoreflectivity analysis in acromegaly: Effects of treatment

European Journal of Endocrinology

Volumn 151, Issue 2, 2004, Pages 179-186

  Ciulla, M M ^d   Epaminonda, P ^a,b   Paliotti, R ^d   Barelli, M V ^d   Ronchi, C ^a   Cappiello, V ^a   Sartorio, A ^c   Buonamici, V ^d   Magrini, F ^d   Beck Peccoz, P ^a   Arosio, Maura ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b San Giuseppe Hospital   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d Istituto di Fisiologia Clinica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; COLLAGEN; OCTREOTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; HYPOPHYSIS ADENOMA; MALE; MEDICAL ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STUDENT T TEST; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ACROMEGALY; ADULT; COLLAGEN TYPE III; ECHOCARDIOGRAPHY; FEMALE; HEART SEPTUM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED;

EID: 4444272797     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510179     Document Type: Article

References (31)

1. Fazio S, Cittadini A, Sabatini D, Merola B, Colao AM, Biondi B et al. Evidence for biventricular involvement in acromegaly: a doppler echocardiography study. European Heart Journal 1993 14 26-33.
2. Saccà L, Cittadini A & Fazio S. Growth hormone and the heart. Endocrine Review 1994 15 555-573.
3. Mathews LS, Enmberg B & Norstedt G. Regulation of rat growth hormone receptor gene expression. Journal of Biological Chemistry 1989 17 9905-9910.
4. Guse AH, Kiess W, Funk B, Kessler U, Berg I & Gercken G. Identification and characterization of insulin like growth factor receptors on adult rat myocytes: linkage to inositol-1.4.5-triphosphate formation. Endocrinology 1992 130 145-151.
5. Isaksson OGP, Eden S & Jansson JO. Mode of action of pituitary growth hormone on target cells. Annual Review of Physiology 1985 47 483-499.
6. Frustaci A, Chimenti C, Setoguchi M, Guerra S, Corsello S, Crea F et al. Cell death in acromegalic cardiomyopathy. Circulation 1999 99 1426-1434.
7. Lie JT & Grossman SJ. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. American Heart Journal 1980 100 41-51.
8. Melmed S. Acromegaly. New England Journal of Medicine 1990 322 966-977.
9. Lopéz-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM, Moya-Mur JL et al. Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension? Journal of Clinical Endocrinology and Metabolism 1997 82 1047-1053.
10. Colao AM, Marzullo P, Di Somma C & Lombardi G. Growth hormone and the heart. Clinical Endocrinology 2001 54 137-154.
11. Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte AM et al. Is the acromegalic cardiomyopathy reversible: Effect of 5 year normalization of growth hormone and insulin like growth factor I levels on cardiac performance. Journal of Clinical Endocrinology and Metabolism 2001 86 1551-1557.
12. Theusen L, Christensen SE, Weeke J, Orskov H & Henningsen P. The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clinical Endocrinology 1989 30 619-625.
13. Ciulla M, Arosio M, Barelli MV, Paliotti R, Porretti S & Valentine P. Blood pressure-independent cardiac hypertrophy in acromegalic patients. Journal of Hypertension 1999 17 1965-1969.
14. Ciulla M, Paliotti R, Hess DB, Tjahja E, Campbell SE, Magrini F et al. Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. Journal of American Society of Echocardiography 1997 10 657-664.
15. Prockop DJ, Kivirikko KI, Tuderman L & Guzman NA. The biosynthesis of collagen and its disorders. New England Journal of Medicine 1979 301 77-85.
16. Fessler JH & Fessler LI. Biosynthesis of procollagen. Annual Review of Biochemistry 1978 47 129.
17. Danne T, Gruters A, Schuppan D, Quantas N, Enders I & Weber B. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders. Journal of Pediatrics 1989 114 257-260.
18. Risteli J, Niemi S, Trivedi P, Maentausta O, Mowat AP & Risteli L. Rapid equilibrium radioimmunoassay for the amino terminal propeptide of type III procollagen. Clinical Chemistry 1988 34 715-718.
19. Tapaneinen P, Risteli L, Knip M, Kaar M-L & Risteli J. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy. Journal of Clinical Endocrinology and Metabolism 1989 67 1244-1249.
20. Sartorio A, Arosio M, Conti A, Ferrero S, Porretti S & Faglia G. Long term monitoring of rec-GH treatment by serial determination of serum aminoterminal propeptide of type III procollagen in children and adults with GH deficiency. Journal of Endocrinological Investigation 1999 22 169-175.
21. Bollerslev J, Møller J, Thomas S, Djøseland O & Christiansen JS. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. European Journal of Endocrinology 1996 135 666-671.
22. Verde G, Santi I, Chiodini P, Cozzi R, Dallabonzana D, Oppizzi G et al. Serum type III procollagen propeptide levels in acromegalic patients. Journal of Clinical Endocrinology and Metabolism 1986 63 1406-1410.
23. Salmela PI, Juustila H, Pyhtinen J, Jokinen K, Alavaikko M & Ruokonene A. Effective clinical response to long term octreotide treatment, with reduced serum concentrations of growth hormone, insulin-like growth factor-I, and the amino-terminal propeptide of type III procollagen in acromegaly. Journal of Clinical Endocrinology and Metabolism 1990 70 1193-1201.
24. Piovesan A, Terzolo M, Reimondo G, Pia A, Codegone A, Osella G et al. Biochemical markers of bone and collagen turnover in acromegaly or Cushing syndrome. Hormone and Metabolic Research 1994 26 234-237.
25. Sartorio A, Monzani M, Conti A, Casati G & Faglia G. Serum amino-terminal propeptide of type III procollagen (PIIINP) levels in patients with acromegaly before and after pituitary adenomectomy. European Journal of Internal Medicine 1993 4 79-83.
26. Sahn DJ, De Maria A, Kisslo J & Weyman A. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978 58 1072-1083.
27. Deveraux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization and comparison to other methods. Hypertension 1987 9 II 19-26.
28. Ciulla M, Paliotti R, Cortelazzi D, Tortora G, Barelli MV, Buonamici V et al. Effects of thyroid hormones on cardiac structure: a tissue characterization study in patients with thyroid disorders before and after treatment. Thyroid 2001 7 613-619.
29. Kossoff G, Grossett WJ, Carpenter DA, Jellins J & Dadd MJ. Principles and classification of soft tissues by grey scale echography. Ultrasound in Medicine and Biology 1976 2 89-105.
30. Clayton RN. Cardiovascular function in acromegaly. Endocrine Reviews 2003 24 272-277.
31. Lombardi G, Colao A, Marzullo P, Biondi B, Palmieri E & Fazio S. the Multicenter Italian Study Group on Lanreotide. Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multicenter study. Journal of Endocrinological Investigation 2002 25 971-976.